• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Granulocytic Airway Inflammation and Clinical Asthma Outcomes.

作者信息

Louis Renaud E, Schleich Florence N

机构信息

Department of Pneumology CHU Liege Liege, Belgium.

出版信息

Am J Respir Crit Care Med. 2021 Apr 1;203(7):797-799. doi: 10.1164/rccm.202102-0356ED.

DOI:10.1164/rccm.202102-0356ED
PMID:33606963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8017566/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f33/8017566/bb13ddaaa435/rccm.202102-0356EDf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f33/8017566/bb13ddaaa435/rccm.202102-0356EDf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f33/8017566/bb13ddaaa435/rccm.202102-0356EDf1.jpg

相似文献

1
Granulocytic Airway Inflammation and Clinical Asthma Outcomes.粒细胞性气道炎症与临床哮喘转归
Am J Respir Crit Care Med. 2021 Apr 1;203(7):797-799. doi: 10.1164/rccm.202102-0356ED.
2
IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?哮喘患者痰液中的白细胞介素-17信使核糖核酸：T细胞驱动的炎症与粒细胞浸润之间的联系？
Respir Res. 2006 Nov 3;7(1):135. doi: 10.1186/1465-9921-7-135.
3
Inhibition of Bruton's tyrosine kinase and IL-2 inducible T-cell kinase suppresses both neutrophilic and eosinophilic airway inflammation in a cockroach allergen extract-induced mixed granulocytic mouse model of asthma using preventative and therapeutic strategy.抑制布鲁顿酪氨酸激酶和白细胞介素 2 诱导的 T 细胞激酶可通过预防和治疗策略抑制蟑螂过敏原提取物诱导的混合粒细胞性哮喘小鼠模型中的中性粒细胞和嗜酸性粒细胞气道炎症。
Pharmacol Res. 2019 Oct;148:104441. doi: 10.1016/j.phrs.2019.104441. Epub 2019 Sep 7.
4
[The expression of nerve growth factor in inflammatory cells of induced sputum from patients with asthma].
Zhonghua Nei Ke Za Zhi. 2003 Nov;42(11):764-7.
5
[Airway inflammation and small airway wall remodeling in neutrophilic asthma].[嗜中性粒细胞性哮喘中的气道炎症与小气道壁重塑]
Beijing Da Xue Xue Bao Yi Xue Ban. 2018 Aug 18;50(4):645-650.
6
[Airway inflammatory phenotypes of asthmatic patients].[哮喘患者的气道炎症表型]
Zhonghua Jie He He Hu Xi Za Zhi. 2015 May;38(5):348-51.
7
Inhibition of BET bromodomains restores corticosteroid responsiveness in a mixed granulocytic mouse model of asthma.抑制 BET 溴结构域可恢复哮喘混合粒细胞小鼠模型对皮质类固醇的反应性。
Biochem Pharmacol. 2018 Aug;154:222-233. doi: 10.1016/j.bcp.2018.05.011. Epub 2018 May 17.
8
Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma.肺功能下降与可变气道炎症模式：严重哮喘的纵向分析。
J Allergy Clin Immunol. 2014 Aug;134(2):287-94. doi: 10.1016/j.jaci.2014.04.005. Epub 2014 Jun 11.
9
Induced sputum in childhood asthma.儿童哮喘中的诱导痰
Hong Kong Med J. 2005 Aug;11(4):289-94.
10
Inflammatory subtypes in asthma: assessment and identification using induced sputum.哮喘中的炎症亚型：利用诱导痰进行评估与识别
Respirology. 2006 Jan;11(1):54-61. doi: 10.1111/j.1440-1843.2006.00784.x.

引用本文的文献

1
Peripheral neutrophils and oxidative stress-associated molecules for predicting the severity of asthma: a cross-sectional study based on multidimensional assessment.用于预测哮喘严重程度的外周血中性粒细胞和氧化应激相关分子：一项基于多维评估的横断面研究
Front Med (Lausanne). 2023 Dec 7;10:1240253. doi: 10.3389/fmed.2023.1240253. eCollection 2023.

本文引用的文献

1
Mixed Sputum Granulocyte Longitudinal Impact on Lung Function in the Severe Asthma Research Program.重度哮喘研究计划中混合痰液粒细胞对肺功能的纵向影响。
Am J Respir Crit Care Med. 2021 Apr 1;203(7):882-892. doi: 10.1164/rccm.202009-3713OC.
2
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.复合 2 型生物标志物策略与基于症状风险的算法调整重度哮喘患者皮质类固醇剂量：一项多中心、单盲、平行组、随机对照试验。
Lancet Respir Med. 2021 Jan;9(1):57-68. doi: 10.1016/S2213-2600(20)30397-0. Epub 2020 Sep 8.
3
Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency.
哮喘加重倾向的证据和加重频率的预测生物标志物。
Am J Respir Crit Care Med. 2020 Oct 1;202(7):973-982. doi: 10.1164/rccm.201909-1813OC.
4
Effectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthma.奥马珠单抗治疗重度变应性哮喘患者报告结局、肺功能和炎症标志物的效果。
Biochem Pharmacol. 2020 Sep;179:113944. doi: 10.1016/j.bcp.2020.113944. Epub 2020 Mar 30.
5
Real-word experience with mepolizumab: Does it deliver what it has promised?美泊利珠单抗的真实世界经验：它是否兑现了承诺？
Clin Exp Allergy. 2020 Jun;50(6):687-695. doi: 10.1111/cea.13601. Epub 2020 Apr 14.
6
Optimal Asthma Control: Time for a New Target.优化哮喘控制：新目标呼之欲出。
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1480-1487. doi: 10.1164/rccm.201910-1934CI.
7
Step-down of inhaled corticosteroids in non-eosinophilic asthma: A prospective trial in real life.非嗜酸性粒细胞性哮喘中吸入性皮质类固醇的降级：真实生活中的前瞻性试验。
Clin Exp Allergy. 2018 May;48(5):525-535. doi: 10.1111/cea.13106. Epub 2018 Mar 6.
8
Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age.严重哮喘研究计划（SARP III）队列的基线特征：年龄差异。
J Allergy Clin Immunol Pract. 2018 Mar-Apr;6(2):545-554.e4. doi: 10.1016/j.jaip.2017.05.032. Epub 2017 Aug 31.
9
Asthma Control and Sputum Eosinophils: A Longitudinal Study in Daily Practice.哮喘控制与痰嗜酸性粒细胞：日常实践中的纵向研究。
J Allergy Clin Immunol Pract. 2017 Sep-Oct;5(5):1335-1343.e5. doi: 10.1016/j.jaip.2017.01.026. Epub 2017 Apr 25.
10
Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts.血浆白细胞介素-6 浓度、代谢功能障碍与哮喘严重程度：两个队列的横断面分析。
Lancet Respir Med. 2016 Jul;4(7):574-584. doi: 10.1016/S2213-2600(16)30048-0. Epub 2016 Jun 6.